PLASMIC score for estimating the risk of ADAMPTS13 deficiency: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "{{CMG}}; {{AE}} {{Saeedeh}} ==Overview== ==PLASMIC score == {{#Widget:PLASMIC score}} </br> '''Risk of ADAMPTS13 deficiency:''' '''Low-risk''' = 0 to 4 points '''Intermediat...")
 
Line 3: Line 3:
==PLASMIC score ==
==PLASMIC score ==
{{#Widget:PLASMIC score}}
{{#Widget:PLASMIC score}}
</br>
<br>
'''Risk of ADAMPTS13 deficiency:'''
'''<big>Risk of ADAMPTS13 deficiency</big>''' '''<big>:</big>'''
'''Low-risk''' = 0 to 4 points  
* '''Low-risk''' = 0 to 4 points  
 
* '''Intermediate risk''' = 5 points
'''Intermediate risk''' = 5 points
* '''High-risk''' = 6 to 7 points
 
<references />
'''High-risk''' = 6 to 7 points

Revision as of 15:39, 23 August 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]

Overview

PLASMIC score

Platelet count (< 30,000/microL)
Hemolysis variables (Retic count > 2.5%, undetectable haptoglobin, indirect billi <2 mg/dL( >34 mcmol/L))
Absence of active cancer
Absence of transplant history (solid, stem cell)
MCV < 90 Fl
INR < 1.5
Serum creatinine < 2 mg/dL (<177 mcmol/L)
Score:

Risk of ADAMPTS13 deficiency :

  • Low-risk = 0 to 4 points
  • Intermediate risk = 5 points
  • High-risk = 6 to 7 points
Retrieved from "https://www.wikidoc.org/index.php?title=PLASMIC_score_for_estimating_the_risk_of_ADAMPTS13_deficiency&oldid=1491804"